Clinical Trial

The Influence of Virtual Reality on Blood Parameters

Study acronym: 8baan
Completed
View on ClinicalTrials.gov →
Summary
The goal of this study is to learn what the impact of exposure to virtual reality content is on the levels of stress-related blood values in healthy volunteers. The main question it aims to answer is: * To compare the levels of stress-related biomarkers before and after relaxing VR-content (Relax Visit); * To compare the levels of stress-related biomarkers before and after stress-inducing VR-content (Rollercoaster Visit). Researchers will compare the Relax and Rollercoaster Visit to see if there is a relationship between the relaxing and stress-inducing VR content on stress-related blood values. Participants will be asked to watch relaxing or stress-inducing VR content for approximately five minutes. Blood will be withdrawn before and after intervention. After 3-5 weeks the study visit will be repeated using the other VR content.
Protocol Amendment History 2 changes
critical Trial completed 2026-04-30
notable Enrollment increased: 24 -> 30 participants 2026-04-30
Trial Details
NCT Number NCT07042178
Lead Sponsor Van Creveldkliniek
Conditions Virtual Reality Pain Distraction, Endocrinology, Haematology
Enrollment 30 participants
Start Date 2025-08-27
Primary Completion 2026-02-20 (estimated)
Study Completion 2026-02-20 (estimated)
Updated on ClinicalTrials.gov 2026-04-29